Lexeo Therapeutics, Inc. (LXEO) is trading at $3.39, up 23.25 percent or $0.68 during Monday's trading, despite reporting a widened net loss of $25.9 million for the fourth quarter compared to $14.2 million in the prior period.
The stock opened at $2.99 and has traded between $2.99 and $3.98 so far, compared to a previous close of $2.71 on the Nasdaq. Trading volume is 4.16 million shares, significantly above the average of 342,756. The stock's 52-week range is $2.32 to $19.50.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.